Browse > Article
http://dx.doi.org/10.5125/jkaoms.2018.44.5.232

Comparison of temporomandibular disorders between menopausal and non-menopausal women  

Farzin, Mitra (Department of Prosthodontics, School of Dentistry, Shiraz University of Medical Sciences)
Taghva, Masumeh (Department of Prosthodontics, School of Dentistry, Shiraz University of Medical Sciences)
Babooie, Moslem (Postgraduate Student of Orthodontics, School of Dentistry, Shiraz University of Medical Sciences)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.44, no.5, 2018 , pp. 232-236 More about this Journal
Abstract
Objectives: Hormonal changes during menopause alter a woman's susceptibility to some disorders. Information regarding the prevalence of temporomandibular disorder (TMD) in menopausal women is limited in the literature. In this study, the prevalence and severity of TMDs were compared between menopausal and non-menopausal women. Materials and Methods: The study included 140 women (69 premenopausal and 71 postmenopausal) 45 to 55 years of age that were examined in Shiraz Dental School, Shiraz in Iran. The Helkimo clinical dysfunction index (Di) was used to evaluate temporomandibular joint (TMJ) dysfunction. The data were analyzed using chi-square and Fisher's exact tests. Results: Occurrence of TMD was significantly higher in menopausal than non-menopausal women (P<0.001). All the TMD criteria based on Helkimo Di except range of mandibular movement were significantly more common in menopausal women. The range of mandibular movement was not significantly different between menopausal and non-menopausal women (P=0.178). Conclusion: The results from this study show that TMD can be considered more common and severe in menopausal than non-menopausal women. This finding indicates that, similar to other conditions in menopausal women such as arthritis and osteoporosis, TMD should be taken into consideration by dental and medical professionals.
Keywords
Temporomandibular joint disorders; Menopause; Prevalence;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Okeson JP. Management of temporomandibular disorders and occlusion. St. Louis: Mosby Elsevier; 2013:129.
2 Ebrahimi M, Dashti H, Mehrabkhani M, Arghavani M, Daneshvar-Mozafari A. Temporomandibular disorders and related factors in a group of Iranian adolescents: a cross-sectional survey. J Dent Res Dent Clin Dent Prospects 2011;5:123-7.
3 De Leeuw R. [Orofacial pain: guidelines for assessment, diagnosis, and management]. 4th ed. Sao Paulo: Quintessence; 2010. Portuguese.
4 Carlsson G, LeResche L. Epidemiology of temporomandibular disorders. In: Sessle B, Bryant P, Dionne R, eds. Progress in pain research and management. Seattle: International Association for the Study of Pain; 1995:211-26.
5 Poveda-Roda R, Bagan JV, Diaz-Fernandez JM, Hernandez-Bazan S, Jimenez-Soriano Y. Review of temporomandibular joint pathology. Part I: classification, epidemiology and risk factors. Med Oral Patol Oral Cir Bucal 2007;12:E292-8.
6 Sari S, Sonmez H. Investigation of the relationship between oral parafunctions and temporomandibular joint dysfunction in Turkish children with mixed and permanent dentition. J Oral Rehabil 2002;29:108-12.   DOI
7 Winocur E, Littner D, Adams I, Gavish A. Oral habits and their association with signs and symptoms of temporomandibular disorders in adolescents: a gender comparison. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:482-7.   DOI
8 Clark GT. Etiologic theory and the prevention of temporomandibular disorders. Adv Dent Res 1991;5:60-6.   DOI
9 Huang GJ, LeResche L, Critchlow CW, Martin MD, Drangsholt MT. Risk factors for diagnostic subgroups of painful temporomandibular disorders (TMD). J Dent Res 2002;81:284-8.   DOI
10 Abubaker AO, Raslan WF, Sotereanos G. Estrogen and progesterone receptors in temporomandibular joint disc of symptomatic and asymptomatic persons: a preliminary study. J Oral Maxillofac Surg 1993;51:1096-100.   DOI
11 Madani AS, Shamsian AA, Hedayati-Moghaddam MR, Fathi-Moghadam F, Sabooni MR, Mirmortazavi A, et al. A cross-sectional study of the relationship between serum sexual hormone levels and internal derangement of temporomandibular joint. J Oral Rehabil 2013;40:569-73.   DOI
12 Abubaker AO, Hebda PC, Gunsolley JN. Effects of sex hormones on protein and collagen content of the temporomandibular joint disc of the rat. J Oral Maxillofac Surg 1996;54:721-7.   DOI
13 Okuda T, Yasuoka T, Nakashima M, Oka N. The effect of ovariectomy on the temporomandibular joints of growing rats. J Oral Maxillofac Surg 1996;54:1201-10.   DOI
14 Yasuoka T, Nakashima M, Okuda T, Tatematsu N. Effect of estrogen replacement on temporomandibular joint remodeling in ovariectomized rats. J Oral Maxillofac Surg 2000;58:189-96.   DOI
15 Landi N, Manfredini D, Lombardi I, Casarosa E, Boseo M. 17-beta estradiol and progesterone serum levels in temporomandibular disorder patients. Minerva Stomatol 2004;53:651-60.
16 Fricton JR, Schiffman EL. Reliability of a craniomandibular. J Dent Res 1986;65:1359-64.   DOI
17 Emodi-Perlman A, Eli I, Friedman-Rubin P, Goldsmith C, Reiter S, Winocur E. Bruxism, oral parafunctions, anamnestic and clinical findings of temporomandibular disorders in children. J Oral Rehabil 2012;39:126-35.   DOI
18 Smith YR, Stohler CS, Nichols TE, Bueller JA, Koeppe RA, Zu- bieta JK. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci 2006;26:5777-85.   DOI
19 Dworkin SF, LeResche L. Research diagnostic criteria for temporo- mandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992;6:301-55.
20 Helkimo M. Studies on function and dysfunction of the masticatory system. IV. Age and sex distribution of symptoms of dysfunction of the masticatory system in Lapps in the north of Finland. Acta Odontol Scand 1974;32:255-67.   DOI
21 Dosi R, Bhatt N, Shah P, Patell R. Cardiovascular disease and menopause. J Clin Diagn Res 2014;8:62-4.
22 Jamshed N, Ozair FF, Aggarwal P, Ekka M. Alzheimer disease in post-menopausal women: intervene in the critical window period. J Midlife Health 2014;5:38-40.
23 Bay-Jensen AC, Slagboom E, Chen-An P, Alexandersen P, Qvist P, Christiansen C, et al. Role of hormones in cartilage and joint metabolism: understanding an unhealthy metabolic phenotype in osteoarthritis. Menopause 2013;20:578-86.
24 Macovei L, Ancuţa C, Belibou C, Chirieac R. [Bone mineral density in patients with rheumatoid arthritis]. Rev Med Chir Soc Med Nat Iasi 2011;115:723-30. Romanian.
25 Torres-Chávez KE, Sanfins JM, Clemente-Napimoga JT, Pelegrini- Da-Silva A, Parada CA, Fischer L, et al. Effect of gonadal steroid hormones on formalin-induced temporomandibular joint inflammation. Eur J Pain 2012;16:204-16.   DOI
26 LeResche L, Mancl L, Sherman JJ, Gandara B, Dworkin SF. Changes in temporomandibular pain and other symptoms across the menstrual cycle. Pain 2003;106:253-61.   DOI
27 Haskin CL, Milam SB, Cameron IL. Pathogenesis of degenerative joint disease in the human temporomandibular joint. Crit Rev Oral Biol Med 1995;6:248-77.   DOI
28 Fischer L, Torres-Chavez KE, Clemente-Napimoga JT, Jorge D, Arsati F, de Arruda Veiga MC, et al. The influence of sex and ovarian hormones on temporomandibular joint nociception in rats. J Pain 2008;9:630-8.   DOI
29 Yun KI, Chae CH, Lee CW. Effect of estrogen on the expression of cytokines of the temporomandibular joint cartilage cells of the mouse. J Oral Maxillofac Surg 2008;66:882-7.   DOI
30 Flake NM, Hermanstyne TO, Gold MS. Testosterone and estrogen have opposing actions on inflammation-induced plasma extravasation in the rat temporomandibular joint. Am J Physiol Regul Integr Comp Physiol 2006;291:R343-8.   DOI
31 Craft RM. Modulation of pain by estrogens. Pain 2007;132 Suppl 1:S3-12.   DOI
32 LeResche L, Saunders K, Von Korff MR, Barlow W, Dworkin SF. Use of exogenous hormones and risk of temporomandibular disorder pain. Pain 1997;69:153-60.   DOI
33 Nekora-Azak A, Evlioglu G, Ceyhan A, Keskin H, Berkman S, Issever H. Estrogen replacement therapy among postmenopausal women and its effects on signs and symptoms of temporomandibular disorders. Cranio 2008;26:211-5.   DOI
34 Wu YW, Kou XX, Bi RY, Xu W, Wang KW, Gan YH, et al. Hip- pocampal nerve growth factor potentiated by $17{\beta}$-estradiol and involved in allodynia of inflamed TMJ in rat. J Pain 2012;13:555- 63.   DOI